NOV 08, 2020 6:40 AM PST

Mouth Spray for Epidermolysis Bullosa in Development

WRITTEN BY: Carmen Leitch

Epidermolysis Bullosa (EB) is a rare genetic disorder that makes the skin incredibly fragile; it forms blisters and can tear from even soft touches. For patients with EB, wounds easily open and scarring is common after they heal. Researchers are now working on a spray that can treat the painful blisters and mouth sores that are hallmarks of this disease, which is usually diagnosed in childhood.

Image credit: Pixabay

The oral spray scientists want to make would deliver antibiotic molecules that can hopefully treat mouth blisters and sores and prevent scarring. The researchers are aiming to develop three formulations, which each deliver a unique, anti-fibrotic molecule (that will reduce the chance of scar formation). Hopefully, within two years at least one of these sprays would then go through a clinical trial to test their safety and efficacy before being made available.

"The hydrogels that we are designing in the Healthcare Technologies Institute have distinctive properties that enable them to stick to the moist tissues inside the mouth," said the project leader Professor Liam Grover, Director of the Healthcare Technologies Institute at the University of Birmingham. "Our aim is to use this formulation to deliver other ingredients that can help treat EB symptoms."

"We regularly see EB patients who are unable to eat properly because of pain and discomfort in their mouths, Even brushing their teeth can be painful and damaging, leading to extremely poor dental health. Developing an oral spray that will help patients to eat and maintain oral hygiene could be a game-changer," said Adrian Heagerty, Honorary Professor of Dermatology at the University of Birmingham.

This research was funded by the UK EB charity, DEBRA.

"The development of this spray could be a giant step forward in helping to alleviate the constant pain and discomfort EB sufferers experience on a daily basis," said Caroline Collins, Director of Research at DEBRA. "The combination of delivery and use of treatments that reduce fibrosis could mean an EB patient is able to properly eat for the first time and maintain basic dental hygiene which many of us take for granted. I am hugely grateful to the team in Birmingham for making this happen."

"There is no cure, yet, for EB and so our primary focus is on managing the pain and other symptoms. We're very grateful to DEBRA for funding this important research," added Anthony Metcalfe, a Professor of Wound Healing at the University.

Sources: AAAS/Eurekalert! via University of Birmingham, DEBRA

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 20, 2021
Microbiology
Bacteria From Cats Could Help Treat Infections
OCT 20, 2021
Bacteria From Cats Could Help Treat Infections
Many animals, including humans and cats, harbor huge colonies of microbes, which may live in places like the skin, or th ...
OCT 21, 2021
Cell & Molecular Biology
In a First, a Working Pig Kidney was Tested in a Person
OCT 21, 2021
In a First, a Working Pig Kidney was Tested in a Person
There are many people out there waiting on transplant lists for organs to become available. Sadly, many of those people ...
NOV 05, 2021
Genetics & Genomics
Solution to a Pigeon Genetic Mystery Provides Insight Into Development
NOV 05, 2021
Solution to a Pigeon Genetic Mystery Provides Insight Into Development
This photo by Sydney Stringham shows the domestic pigeons that were bred by the researchers for this research.
NOV 07, 2021
Cell & Molecular Biology
How Cells Use Messengers to Signal to One Another
NOV 07, 2021
How Cells Use Messengers to Signal to One Another
In recent years, researchers have discovered the importance of a kind of antenna that is found on most cells, a structur ...
NOV 11, 2021
Microbiology
Is Coronavirus Spillover More Common Than We Knew?
NOV 11, 2021
Is Coronavirus Spillover More Common Than We Knew?
While many people are most familiar with the coronavirus that causes COVID-19, which is called SARS-CoV-2, there are man ...
DEC 08, 2021
Clinical & Molecular DX
Scaling Down to Go Big: An Overview of the Lab-on-a-Chip
DEC 08, 2021
Scaling Down to Go Big: An Overview of the Lab-on-a-Chip
By Julianne Davis - Technical Writer and Support Scientist at Biotium The Rise of the Lab-on-a-Chip With the advent of m ...
Loading Comments...